TY  - GEN
AU  - Sherman,Scott K
AU  - Lange,Joel J
AU  - Dahdaleh,Fadi S
AU  - Rajeev,Rahul
AU  - Gamblin,T Clark
AU  - Polite,Blase N
AU  - Turaga,Kiran K
TI  - Cost-effectiveness of Maintenance Capecitabine and Bevacizumab for Metastatic Colorectal Cancer
SN  - 2374-2445
PY  - 2019///1206
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Bevacizumab
KW  - administration & dosage
KW  - Capecitabine
KW  - Colorectal Neoplasms
KW  - drug therapy
KW  - Cost-Benefit Analysis
KW  - Disease Progression
KW  - Drug Costs
KW  - Female
KW  - Humans
KW  - Maintenance Chemotherapy
KW  - economics
KW  - Male
KW  - Markov Chains
KW  - Medicare
KW  - Middle Aged
KW  - Models, Economic
KW  - Neoplasm Metastasis
KW  - Quality of Life
KW  - Quality-Adjusted Life Years
KW  - Randomized Controlled Trials as Topic
KW  - Time Factors
KW  - Treatment Outcome
KW  - United States
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1001/jamaoncol.2018.5070
ER  -